- Home
- CPHI vs ACCS Comparison
CPHI vs ACCS Comparison
Compare CPHI & ACCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CPHI | ACCS |
|---|---|---|
| Founded | N/A | 1988 |
| Country | China | United States |
| Employees | N/A | 91 |
| Industry | Biotechnology: Pharmaceutical Preparations | Publishing |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 26.3M | 28.7M |
| IPO Year | 2008 | N/A |
Fundamental Metrics
Financial Performance| Metric | CPHI | ACCS |
|---|---|---|
| Price | $0.76 | $6.48 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $14.00 |
| AVG Volume (30 Days) | ★ 321.3K | 8.2K |
| Earning Date | 05-11-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $4,144,268.00 | N/A |
| Revenue This Year | N/A | $7.40 |
| Revenue Next Year | N/A | $8.75 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.38 | $6.48 |
| 52 Week High | $2.60 | $13.35 |
Technical Indicators
Market Signals| Indicator | CPHI | ACCS |
|---|---|---|
| Relative Strength Index (RSI) | 51.74 | 30.62 |
| Support Level | $0.52 | N/A |
| Resistance Level | $1.87 | $8.76 |
| Average True Range (ATR) | 0.19 | 0.46 |
| MACD | 0.03 | -0.19 |
| Stochastic Oscillator | 34.15 | 0.00 |
Price Performance
Historical ComparisonAbout CPHI China Pharma Holdings Inc.
China Pharma Holding Inc is a drug manufacturing company. It is mainly engaged in the development, manufacture, and marketing of pharmaceutical products for human use in connection with a variety of high-incidence and high-mortality diseases and medical conditions prevalent in the People's Republic of China. The company mainly manufactures pharmaceutical products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. The product line of the company includes cefaclor dispersible tablets, clarithromycin granules, roxithromycin dispersible tablets, andrographolide tablets, ozagrel sodium for injection, gastrodin injection, and others.
About ACCS ACCESS Newswire Inc.
ACCESS Newswire Inc is a Public Relations (PR) and Investor Relations (IR) solutions provider. The group focuses on innovation, customer service, and value-driven offerings, ACCESS Newswire empowers brands.